Approval · Notice of Compliance 15768 · 2014
VIMIZIM: Notice of Compliance 15768
Issued July 2, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15768
- Date
- July 2, 2014
- Company
- Biomarin International LimitedRingaskiddy, Cork, Ireland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Enzyme replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIMIZIM | 02427184 | Marketed |
Medicinal ingredients
- ELOSULFASE ALFA 1 MG per ML